Research Topics
Genomes and GenesSpecies | Iliyan IvanovSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Parental substance abuse and function of the motivation and behavioral inhibition systems in drug-naïve youthIliyan Ivanov
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, United States
Psychiatry Res 201:128-35. 2012..These results suggest that a functional mismatch between these two systems may represent one possible biological underpinning of SA risk, which is conferred by a parental history of addiction...
Neurorobiology and evidence-based biological treatments for substance abuse disordersIliyan S Ivanov
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
CNS Spectr 11:864-77. 2006..This article will also review the pharmacologic agents used in the treatment of substance abuse disorders and presents evidence-based data for their safety, efficacy, and feasibility of use in different patient populations...
Inhibitory control deficits in childhood and risk for substance use disorders: a reviewIliyan Ivanov
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
Am J Drug Alcohol Abuse 34:239-58. 2008..Hypotheses developed using this approach can be more definitively evaluated in longitudinal studies with these same populations, extending through the period of maximal risk for SUD in adolescence and early adulthood...
The effect of trauma on stress reactivity in aggressive youthIliyani Ivanov
Mount Sinai School of Medicine, New York, United States
Psychiatry Res 189:396-402. 2011..These results suggest that aggressive youth with personal history of trauma may exhibit unique biological characteristics, which may have important implications for classification and treatment...
Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorderIliyan Ivanov
ivision of Child and Adolescent Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
Am J Psychiatry 167:397-408. 2010..The authors used anatomical MRI to examine the morphology of the thalamus in youths with ADHD and healthy comparison youths...
Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorderKurt P Schulz
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Arch Gen Psychiatry 69:952-61. 2012..These results represent a first step in delineating the neurobiological basis of differential response to stimulant and nonstimulant medications for ADHD...
Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorderLoren J Sobel
Department of Psychiatry, New York State Psychiatric Institute and the College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
Am J Psychiatry 167:977-86. 2010..The authors examined the morphologic features of the basal ganglia nuclei (caudate, putamen, and globus pallidus) in children with ADHD...
Dopamine transporter gene variation modulates activation of striatum in youth with ADHDAnne Claude Bedard
Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, One Gustave L Levy Place, New York, NY 10029, USA
Neuroimage 53:935-42. 2010..These findings provide preliminary evidence that neural activity related to inhibitory control may differ as a function of DAT1 3'UTR genotype in youth with ADHD...
Guanfacine potentiates the activation of prefrontal cortex evoked by warning signalsSuzanne M Clerkin
Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
Biol Psychiatry 66:307-12. 2009..We tested the role that postsynaptic alpha(2A) adrenoceptors play in the activation of DLPFC evoked by warning cues using a placebo-controlled challenge with the alpha(2A) agonist guanfacine...
The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhoodSeth C Harty
Neuropsychology Doctoral Program, Clinical Psychology, CUNY Graduate Center, New York, New York, USA
J Child Adolesc Psychopharmacol 21:331-9. 2011..To examine late adolescent substance use outcomes in relation to childhood conduct disorder (CD) and psychostimulant treatment in urban youth found to have attention-deficit/hyperactivity disorder (ADHD) in childhood...
Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorderMary Solanto
Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York 10029, USA
J Child Adolesc Psychopharmacol 19:663-71. 2009..It is the first such study to enroll a sample comprised exclusively of children, all but one of whom had no prior exposure to ADHD medications...
Enlargement of thalamic nuclei in Tourette syndromeAnn M Miller
Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, USA
Arch Gen Psychiatry 67:955-64. 2010..Previous imaging studies have shown modifications of the basal ganglia and cortical targets in individuals with Tourette syndrome (TS), but less is known regarding the role of the thalamus in TS pathogenesis...
Effects of motivation on reward and attentional networks: an fMRI studyIliyan Ivanov
Department of Psychiatry, Mount Sinai School of Medicine One Gustave L Levy Place, New York, New York, 10029
Brain Behav 2:741-53. 2012....
Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disordersJeffrey H Newcorn
Mount Sinai School of Medicine, New York, USA
Pediatr Ann 36:564-74. 2007
Posterior cortical atrophy: an exemplar for renovating diagnostic formulation in neuropsychiatryMartin A Goldstein
Department of Neurology, Mount SinaiSchool of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Compr Psychiatry 52:326-33. 2011....
The challenges of psychopharmacological management of children with severe developmental disabilitiesIliyan Ivanov
Mount Sinai School of Medicine, New York, New York, USA
J Child Adolesc Psychopharmacol 16:793-9. 2006
